🇺🇸 FDA
Patent

US 12157762

Tethered interleukin-15 and interleukin-21

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 12157762 (Tethered interleukin-15 and interleukin-21) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/59, A61K40/11